Ex parte TENG - Page 5




          Appeal No. 1999-1792                                                        
          Application No. 08/879,477                                                  


      an       Examiner is under a burden to make out a prima facie case              
      of       obviousness.  If that burden is met, the burden of going               
      forward       then shifts to the applicant to overcome the prima                
      facie case with argument and/or evidence.  Obviousness, is then                 
      determined on the basis of the evidence as a whole and the                      
      relative      persuasiveness of the arguments.  See In re Oetiker,              
      977 F.2d      1443, 1445, 24 USPQ2d 1443, 1444 (Fed. Cir. 1992);                
      In re Hedges,      783 F.2d 1038, 1039, 228 USPQ 685, 686 (Fed.                 
      Cir. 1986); In re       Piasecki, 745 F.2d 1468, 1472, 223 USPQ                 
      785, 788 (Fed. Cir.     1984); and In re Rinehart, 531 F.2d 1048,               
      1052, 189 USPQ 143, 147      (CCPA 1976).  We are further guided by             
      the precedent of our reviewing court that the limitations from                  
      the disclosure are not       to be imported into the claims.  In re             
      Lundberg, 244 F.2d 543,      113 USPQ 530 (CCPA 1957); In re                    
      Queener, 796 F.2d 461, 230 USPQ        438 (Fed. Cir. 1986).  We                
      also note that the arguments not made       separately for any                  
      individual claim or claims are considered        waived.  See 37 CFR            
      § 1.192(a) and (c).  In re Baxter Travenol       Labs., 952 F.2d                
      388, 391, 21 USPQ2d 1281, 1285 (Fed. Cir. 1991)       (“It is not               
      the function of this court to examine the claims in                             
          greater detail than argued by an appellant, looking for                     
                                          5                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007